Guidelines for registration of biotherapeutic protein products  prepared by recombinant DNA technology

dc.contributor.author	Ethiopian Food and Drug Authority
dc.date.accessioned	2023-12-27T06:27:07Z
dc.date.available	2023-12-27T06:27:07Z
dc.date.issued	2018
dc.identifier.uri	http://repository.iphce.org/xmlui/handle/123456789/2658
dc.description.abstract	Ethiopia has been made huge strides to improve access to safe, quality and efficacious medicines to the public. The Ethiopian Food, Medicine and Healthcare Administration and Control Authority is responsible to ensure the safety, quality and effectiveness of biotherapeutic protein products prepared by recombinant deoxyribonucleic acid technology (rDNA-derived biotherapeutics). These products are pharmaceutical products that fall in this jurisdiction and must be regulated as stipulated in the proclamation No. 661/2009.	en_US
dc.language.iso	English	en_US
dc.subject	Health information technology & information management	en_US
dc.title	Guidelines for registration of biotherapeutic protein products prepared by recombinant DNA technology	en_US
dc.type	Guideline	en_US